Phosphatases
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #1051S | 100 μg | 16,000 | |
|
PP2A, B subunit抗体製品一覧
| 使用目的 | |
| PP2A B Subunit (100C1) Rabbit mAb (#2290) の反応をブロックし、抗体の特異性を確認するために使用 |
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma using PP2A Subunit (100C1) Rabbit mAb #2290 in the presence of control peptide (left) or PP2A Subunit (100C1) Blocking Peptide (right).
Protein phosphatase type 2A (PP2A) is an essential protein serine/threonine phosphatase that is conserved in all eukaryotes. PP2A is a key enzyme within various signal transduction pathways as it regulates fundamental cellular activities such as DNA replication, transcription, translation, metabolism, cell cycle progression, cell division, apoptosis and development (1-3). The core enzyme consists of catalytic C and regulatory A (or PR65) subunits, with each subunit represented by α and β isoforms (1). Additional regulatory subunits belong to four different families of unrelated proteins. Both the B (or PR55) and B' regulatory protein families contain α, β, γ and δ isoforms, with the B' family also including an ε protein. B'' family proteins include PR72, PR130, PR59 and PR48 isoforms, while striatin (PR110) and SG2NA (PR93) are both members of the B''' regulatory protein family. These B subunits competitively bind to a shared binding site on the core A subunit (1). This variable array of holoenzyme components, particularly regulatory B subunits, allows PP2A to act in a diverse set of functions. PP2A function is regulated by expression, localization, holoenzyme composition and post-translational modification. Phosphorylation of PP2A at Tyr307 by Src occurs in response to EGF or insulin and results in a substantial reduction of PP2A activity (4). Reversible methylation on the carboxyl group of Leu309 of PP2A has been observed (5,6). Methylation alters the conformation of PP2A, as well as its localization and association with B regulatory subunits (6-8).
-
Janssens, V. and Goris, J. (2001) Biochem. J. 353, 417-439.
-
Zolnierowicz, S. (2000) Biochem. Pharmacol. 60, 1225-1235.
-
Milward, T.A. et al. (1999) Trends Biochem. Sci. 24, 186-191.
-
Chen, J. et al. (1992) Science 257, 1261-1264.
-
Turowski, P. et al. (1995) J. Cell. Biol. 129, 397-410.
-
Lee, J. et al. (1996) Proc. Natl. Acad. Sci. USA 93, 6043-6047.
-
Tolstykh, T. et al. (2000) EMBO J. 19, 5682-5691.
-
Yu, X.X. et al. (2001) Mol. Biol. Cell 12, 185-199.